Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
21.69
-1.35 (-5.84%)
Jan 28, 2026, 4:00 PM EST - Market closed
Surrozen Market Cap
Surrozen has a market cap or net worth of $185.87 million as of January 29, 2026. Its market cap has increased by 412.96% in one year.
Market Cap
185.87M
Enterprise Value
111.62M
1-Year Change
412.96%
Ranking
Category
Stock Price
$21.69
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $185.87M, an increase of 54.05%. That is a compound annual growth rate of 8.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 197.40M | 1.90% |
| Dec 31, 2025 | 193.71M | 315.39% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 181.30M |
| Camp4 Therapeutics | 178.47M |
| ProQR Therapeutics | 178.03M |
| Minerva Neurosciences | 176.13M |
| Eledon Pharmaceuticals | 175.37M |
| Nkarta | 174.73M |
| NeOnc Technologies Holdings | 173.32M |
| Corbus Pharmaceuticals Holdings | 173.06M |